Home>News> Thermo Fisher expands biologics manufacturing at 3 sites

Thermo Fisher expands biologics manufacturing at 3 sites

With biopharmaceuticals dominating the drug development landscape, Thermo Fisher Scientific says it needs more capacity throughout its manufacturing network. To that end, its CDMO operations will invest $150 million in three sites.
 
The company says the investments will provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing at sites in Greenville, North Carolina, as well as Monza and Ferentino, Italy. Each site will get aseptic filling lines and isolator technology. Construction is slated to be complete within 24 months.

Tags: